Parkside Investments LLC Buys Shares of 900 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Parkside Investments LLC bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 900 shares of the medical equipment provider’s stock, valued at approximately $239,000.

A number of other hedge funds have also made changes to their positions in ISRG. BlackRock Inc. grew its position in shares of Intuitive Surgical by 5.6% in the third quarter. BlackRock Inc. now owns 27,887,777 shares of the medical equipment provider’s stock valued at $5,227,284,000 after purchasing an additional 1,477,885 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of Intuitive Surgical by 3.3% in the second quarter. Price T Rowe Associates Inc. MD now owns 25,692,735 shares of the medical equipment provider’s stock valued at $5,156,788,000 after purchasing an additional 816,066 shares in the last quarter. Goldman Sachs Group Inc. grew its position in shares of Intuitive Surgical by 49.0% in the second quarter. Goldman Sachs Group Inc. now owns 1,888,228 shares of the medical equipment provider’s stock valued at $378,987,000 after purchasing an additional 621,063 shares in the last quarter. Grantham Mayo Van Otterloo & Co. LLC purchased a new stake in shares of Intuitive Surgical in the second quarter valued at approximately $121,152,000. Finally, Mackenzie Financial Corp grew its position in shares of Intuitive Surgical by 244.5% in the third quarter. Mackenzie Financial Corp now owns 730,312 shares of the medical equipment provider’s stock valued at $136,890,000 after purchasing an additional 518,321 shares in the last quarter. Institutional investors and hedge funds own 81.96% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on ISRG shares. Deutsche Bank Aktiengesellschaft upped their price target on Intuitive Surgical from $230.00 to $245.00 in a research report on Wednesday, January 25th. Citigroup lowered their price objective on Intuitive Surgical from $318.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, January 25th. StockNews.com initiated coverage on Intuitive Surgical in a research report on Thursday. They issued a “hold” rating for the company. Argus increased their price objective on Intuitive Surgical from $265.00 to $320.00 and gave the stock a “buy” rating in a research report on Thursday, December 22nd. Finally, BTIG Research lowered their price objective on Intuitive Surgical from $316.00 to $279.00 and set a “buy” rating for the company in a research report on Wednesday, January 25th. Six equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $273.83.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 1,629 shares of the firm’s stock in a transaction on Friday, January 27th. The stock was sold at an average price of $250.00, for a total value of $407,250.00. Following the sale, the executive vice president now directly owns 6,769 shares in the company, valued at $1,692,250. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Intuitive Surgical news, EVP Robert Desantis sold 1,629 shares of the firm’s stock in a transaction on Friday, January 27th. The stock was sold at an average price of $250.00, for a total value of $407,250.00. Following the sale, the executive vice president now directly owns 6,769 shares in the company, valued at $1,692,250. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Marshall Mohr sold 33,249 shares of the firm’s stock in a transaction dated Monday, February 13th. The stock was sold at an average price of $245.61, for a total value of $8,166,286.89. Following the transaction, the vice president now directly owns 20,751 shares in the company, valued at approximately $5,096,653.11. The disclosure for this sale can be found here. Insiders have sold a total of 82,396 shares of company stock worth $20,438,478 over the last ninety days. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Trading Down 1.1 %

Shares of NASDAQ ISRG opened at $237.80 on Friday. The stock has a market cap of $83.29 billion, a P/E ratio of 64.97, a PEG ratio of 4.79 and a beta of 1.29. Intuitive Surgical, Inc. has a 12-month low of $180.07 and a 12-month high of $308.97. The business’s fifty day simple moving average is $244.17 and its 200-day simple moving average is $238.37.

Intuitive Surgical (NASDAQ:ISRG – Get Rating) last announced its quarterly earnings data on Tuesday, January 24th. The medical equipment provider reported $1.23 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.25 by ($0.02). Intuitive Surgical had a net margin of 21.25% and a return on equity of 11.27%. The company had revenue of $1.66 billion during the quarter, compared to analyst estimates of $1.66 billion. During the same quarter in the previous year, the business posted $1.30 earnings per share. The firm’s revenue was up 6.7% on a year-over-year basis. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 4.21 EPS for the current fiscal year.

About Intuitive Surgical

(Get Rating)

Intuitive Surgical, Inc engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G.